Lpl Financial LLC Syndax Pharmaceuticals Inc Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$6.65 - $12.03 $75,510 - $136,600	-11,355 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.43 - $9.22 $61,657 - $104,693	11,355 New	11,355 $100,000
Q4 2018 Feb 07, 2019	SELL	$3.6 - $8.42 $50,868 - $118,974	-14,130 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.33 - $8.08 $1,266 - $1,616	200 Added 1.44%	14,130 $114,000
Q2 2018 Aug 14, 2018	BUY	$6.93 - $14.63 $96,534 - $203,795	13,930 New	13,930 $98,000

196

90M

353K

207K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.28B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.